Synergistic immune and antinociceptive effects induced from the combination of two different vaccines against morphine/heroin in mouse

References

• Tetrault JM, Fiellin DA. Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. Drugs. 2012;72(2):217–28. doi:10.2165/11597520-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Rahimi-Movaghar A, Amin-Esmaeili M, Hefazi M, Yousefi-Nooraie R. Pharmacological therapies for maintenance treatments of opium dependence. Cochrane Database Syst Rev. 2013. doi:10.1002/14651858.CD007775.
   PubMed Web of Science ®Google Scholar
• Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MM, Mayet S. Heroin anticraving medications: a systematic review. Am J Drug Alcohol Abuse. 2010;36:332–41. doi:10.3109/00952990.2010.505991.
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis. 2010;29:200–16. doi:10.1080/10550881003684798.
   PubMed Web of Science ®Google Scholar
• Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev. 2008;8:CD005031.
   Google Scholar
• Pasternak GW. Preclinical pharmacology and opioid combinations. Pain Med. 2012;13(Suppl 1):S4–11. doi:10.1111/j.1526-4637.2012.01335.x.
   PubMed Web of Science ®Google Scholar
• Carrera MR, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Suppression of psychoactive effects of cocaine by active immunization. Nature. 1995;378(6558):727–30. doi:10.1038/378727a0.
   PubMed Web of Science ®Google Scholar
• Cerny EH, Cerny T. Vaccines against nicotine. Hum Vaccine. 2009;5(4):200–05. doi:10.4161/hv.5.4.7310.
   PubMed Web of Science ®Google Scholar
• Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Nicotine vaccines. CNS Neurol Disord Drug Targets. 2011;10(8):905–15. doi:10.2174/187152711799219343.
   PubMed Web of Science ®Google Scholar
• Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, French TL, Thompson TL, Schad VC, Greenstein JL, et al. Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med. 1996;2(10):1129–32. doi:10.1038/nm1096-1129.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 2002;20:1196–204. doi:10.1016/S0264-410X(01)00425-X.
   PubMed Web of Science ®Google Scholar
• Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry. 2005;58:158–64. doi:10.1016/j.biopsych.2005.04.032.
   PubMed Web of Science ®Google Scholar
• Anton B, Leff P. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine. 2006;24:3232–40. doi:10.1016/j.vaccine.2006.01.047.
   PubMed Web of Science ®Google Scholar
• Anton B, Salazar A, Flores A, Matus M, Marin R, Hernandez JA, Leff P. Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Hum Vaccine. 2009;5:214–29. doi:10.4161/hv.5.4.7556.
   PubMed Web of Science ®Google Scholar
• Schlosburg JE, Vendruscolo LF, Bremer PT, Lockner JW, Wade CL, Nunes AA, Stowe GN, Edwards S, Janda KD, Koob GF. Dynamic vaccine blocks relapse to compulsive intake of heroin. Proc Natl Acad Sci U S A. 2013;(22):9036–41. doi:10.1073/pnas.1219159110.
   PubMed Web of Science ®Google Scholar
• Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR. Changes in heroin self-administration by a rhesus monkey after morphine immunization. Nature. 1974;252:708–10. doi:10.1038/252708a0.
   PubMed Web of Science ®Google Scholar
• Bremer PT, Janda KD. Investigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performance. J Med Chem. 2012;55:10776–80. doi:10.1021/jm301262z.
   PubMed Web of Science ®Google Scholar
• Li QQ, Luo YX, Sun CY, Xue YX, Zhu WL, Shi HS, Zhai HF, Shi J, Lu L. A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats. J Neurochem. 2011;119:1271–81. doi:10.1111/j.1471-4159.2011.07502.x.
   PubMed Web of Science ®Google Scholar
• Raleigh MD, Pravetoni M, Harris AC, Birnbaum AK, Pentel PR. Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats. J Pharmacol Exp Ther. 2013;344:397–406. doi:10.1124/jpet.112.201194.
   PubMed Web of Science ®Google Scholar
• Stowe GN, Schlosburg JE, Vendruscolo LF, Edwards S, Misra KK, Schulteis G, Zakhari JS, Koob GF, Janda KD. Developing a vaccine against multiple psychoactive targets: a case study of heroin. CNS Neurol Disord Drug Targets. 2011a;10:865–75. doi:10.2174/187152711799219316.
   PubMed Web of Science ®Google Scholar
• Stowe GN, Vendruscolo LF, Edwards S, Schlosburg JE, Misra KK, Schulteis G, Mayorov AV, Zakhari JS, Koob GF, Janda KD. A vaccine strategy that induces protective immunity against heroin. J Med Chem. 2011b;54:5195–204. doi:10.1021/jm200461m.
   PubMed Web of Science ®Google Scholar
• Kosten TA, Shen XY, O’Malley PW, Kinsey BM, Lykissa ED, Orson FM, Kosten TR. A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:223–29. doi:10.1016/j.pnpbp.2013.05.012.
   PubMed Web of Science ®Google Scholar
• Torres OB, Matyas GR, Rao M, Peachman KK, Jalah R, Beck Z, Michael NL, Rice KC, Jacobson AE, Alving CR. Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant. NPJ Vaccines. 2017;2:13. doi:10.1038/s41541-017-0013-9.
   PubMed Web of Science ®Google Scholar
• Sulima A, Jalah R, Antoline JFG, Torres OB, Imler GH, Deschamps JR, Beck Z, Alving CR, Jacobson AE, Rice KC, et al. Analogue that can serve as a vaccine hapten to induce antibodies that block the effects of heroin and its metabolites in rodents and that cross-react immunologically with related drugs of abuse. J Med Chem. 2018;61(1):329–43. doi:10.1021/acs.jmedchem.7b01427.
   PubMed Web of Science ®Google Scholar
• Jalah R, Torres OB, Mayorov AV, Li F, Antoline JF, Jacobson AE, Rice KC, Deschamps JR, Beck Z, Alving CR, et al. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers. Bioconjug Chem. 2015;26(6):1041–53. doi:10.1021/acs.bioconjchem.5b00085.
   PubMed Web of Science ®Google Scholar
• Salazar-Juárez A, Barbosa-Méndez S, Feregrino-Alonso MI, Hernández-Miramontes R, Ramos-Ochoa E, Bonilla-Reyes E, Jacinto-Gutierrez S, Pentel P, Antón B. Nuevas Vacunas contra la morfina/heroína. Salud Mental. 2013;36:219–27. doi:10.17711/SM.0185-3325.2013.028.
   Web of Science ®Google Scholar
• Pravetoni M, Raleigh MD, Le Naour M, Tucker AM, Harmon TM, Jones JM, Birnbaum AK, Portoghese PS, Pentel PR. Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine. 2012;30(31):4617–24. doi:10.1016/j.vaccine.2012.04.101.
   PubMed Web of Science ®Google Scholar
• Townsend EA, Bremer PT, Faunce KE, Negus SS, Jaster AM, Robinson HL, Janda KD, Banks ML. Evaluation of a dual fentanyl/heroin vaccine on the antinociceptive and reinforcing effects of a fentanyl/heroin mixture in male and female rats. ACS Chem Neurosci. 2020;11(9):1300–10. doi:10.1021/acschemneuro.0c00064.
   PubMed Web of Science ®Google Scholar
• Fink AL, Engle K, Ursin RL, Tang WY, Klein SL. Biological sex affects vaccine efficacy and protection against influenza in mice. Proc Natl Acad Sci U S A. 2018;115:12477‐12482. doi:10.1073/pnas.1805268115.
   Web of Science ®Google Scholar
• Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109:9‐15. doi:10.1093/trstmh/tru167.
   PubMed Web of Science ®Google Scholar
• Méndez SB, Matus-Ortega M, Miramontes RH, Salazar-Juárez A. Effect of the morphine/heroin vaccine on opioid and non-opioid drug-induced antinociception in mice. Eur J Pharmacol. 2020. doi:10.1016/j.ejphar.2020.173718.
   PubMed Web of Science ®Google Scholar
• Simon EJ, Dole WP, Hiller JM. Coupling of a new, active morphine derivative to sepharose for affinity chromatography. Proc Natl Acad Sci U S A. 1972;69:1835–37. doi:10.1073/pnas.69.7.1835.
   PubMed Web of Science ®Google Scholar
• Wainer BH, Fitch FW, Fried J, Rothberg RM. A measurement of the specificities of antibodies to morphine-6-succinyl-BSA by competitive inhibition of 14 C-morphine binding. J Immunol. 1973a;110:667–73.
   PubMed Web of Science ®Google Scholar
• Wainer BH, Fitch FW, Rothberg RM, Schuster CR. In vitro morphine antagonism by antibodies. Nature. 1973b;241:537–38. doi:10.1038/241537a0.
   PubMed Web of Science ®Google Scholar
• Spector S, Berkowitz B, Flynn EJ, Peskar B. Antibodies to morphine,barbiturates, and serotonin. Pharmacol Rev. 1973;25:281–91.
   PubMed Web of Science ®Google Scholar
• Spector S, Parker CW. Morphine: radioimmunoassay. Science. 1970;168:1347–48. doi:10.1126/science.168.3937.1347.
   PubMed Web of Science ®Google Scholar
• D’Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941;72:74–78.
   Google Scholar
• Dewey WL, Harris LS, Howes JF, Nuite JA. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther. 1970;175:435–42.
   PubMed Web of Science ®Google Scholar
• Tchilian EZ, Ronan EO, De Lara C, Lee LN, Franken KL, Vordermeier MH, Ottenhoff TH, Beverley PC. Simultaneous immunization against tuberculosis. PLoS One. 2011;6:e27477. doi:10.1371/journal.pone.0027477.
   PubMed Web of Science ®Google Scholar
• Rieger MA, Hofmann F, Michaelis M. Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view. Int J Occup Med Environ Health. 2004;17:379–91.
   PubMedGoogle Scholar
• Fukuda T, Iwaki M, Komiya T, Shibayama K, Takahashi M, Nakashima H. Effects of simultaneous immunization of Haemophilus influenzae type b conjugate vaccine and diphtheria-tetanus-acellular pertussis vaccine on anti-tetanus potencies in mice, guinea pigs, and rats. Jpn J Infect Dis. 2013;66:41–45. doi:10.7883/yoken.66.41.
   PubMed Web of Science ®Google Scholar
• Boot HJ, Schipper CM. Simultaneous vaccination with Prevenar and multicomponent vaccines for children: interference or no interference? Hum Vaccine. 2009;5:15–17. doi:10.4161/hv.5.1.6520.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Forstén A, Desole MG, Ferrera G, Caubet M, Mesaros N, Boutriau D. A combined haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus toxoid conjugate vaccine (Hib-MenC-TT) is immunogenic and well-tolerated when co-administered with DTPa-HBV-IPV at 3, 5, and 11 months of age: results of an open, randomized, controlled study. Pediatr Infect Dis J. 2013;32:521–9. doi:10.1097/INF.0b013e31827e22e3.
   Google Scholar
• Madan RA, Heery CR, Gulley JL. Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity. Oncoimmunology. 2012;1:1167–68. doi:10.4161/onci.20591.
   PubMed Web of Science ®Google Scholar